Revenue
No reported data
Passage BIO, Inc. (PASG)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Research & development | $23.3M | $40.2M | $61.4M | $86.1M | $117.7M | $81.8M | $29.7M |
| Operating income | −$49.3M | −$70.4M | −$108.4M | −$138.4M | −$185.7M | −$112.9M | −$37.2M |
| EBITDAderived | −$48.6M | −$67.3M | −$104.7M | −$134.7M | −$184.2M | −$112.1M | −$37.1M |
| Net income | −$45.5M | −$64.8M | −$102.1M | −$136.1M | −$185.4M | −$112.2M | −$45.6M |
| Basic EPSper diluted share | -$14.35 | -$21.04 | -$1.86 | -$2.50 | -$3.48 | -$2.91 | -$10.77 |
| Diluted EPSper diluted share | -$14.35 | -$21.04 | -$1.86 | -$2.50 | -$3.48 | -$2.91 | -$10.77 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026Form 4 | Nichols Weston +1TenPercentOwner | BuyCommon stock, $0.0001 par value per share ("Common Stock") · indirect | 50.1K | $4.12 | $206.2K | 673.8K |
| Jan 8, 2026Form 4 | Borthwick KathleenCFO | SellCommon Stock | 2.1K | $18.44 | $38.0K | 5.4K |
| Jan 8, 2026Form 4 | Chou WilliamPRESIDENT AND CEO | SellCommon Stock | 4.1K | $18.44 | $75.2K | 6.5K |
| Sep 15, 2025Form 4 | Nichols Weston +1TenPercentOwner | BuyCommon Stock · indirect | 11.9K | $6.99 | $83.2K | 623.7K |
| Sep 12, 2025Form 4 | Nichols Weston +1TenPercentOwner | BuyCommon Stock · indirect | 19.8K | $6.99 | $138.3K | 611.8K |